✦ LIBER ✦

A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis C

✍ Scribed by Annagiulia Gramenzi; Pietro Andreone; Carmela Cursaro; Gabriella Verucchi; Sergio Boccia; Pier Luigi Giacomoni; Silvia Galli; Giuliano Furlini; Maurizio Biselli; Stefania Lorenzini; Luciano Attard; Fiorenza Bonvicini; Mauro Bernardi

Publisher: Springer Japan
Year: 2007
Tongue: English
Weight: 142 KB
Volume: 42
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-007-2006-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized trial of interferon beta-1a w

Randomized trial of interferon beta-1a with or without ribavirin in Asian patients with chronic hepatitis C

✍ Henry L. Y. Chan; Hong Ren; Wan C. Chow; Theodore Wee 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 1 views

Efficacy of re-treatment with pegylated

Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan

✍ Tsugiko Oze; Naoki Hiramatsu; Takayuki Yakushijin; Kiyoshi Mochizuki; Masahide O 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 297 KB

High-dose ribavirin in combination with

High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C

✍ Karin Lindahl; Lars Stahle; Annette Bruchfeld; Robert Schvarcz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Treatment of chronic hepatitis C patient

Treatment of chronic hepatitis C patients not responding to combination therapy with ribavirin and interferon α — hype or hope?

✍ Wolfgang Vogel 📂 Article 📅 2004 🏛 Springer Vienna 🌐 English ⚖ 440 KB

Combined treatment with interferon alpha

Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone

✍ R. Schvarcz; Z. B. Yun; A. Sönnerborg; O. Weiland 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Ten patients with chronic hepatitis C, six of whom had not responded and four of whom had responded in a non-sustained fashion to interferon-alpha treatment alone, were given interferon alpha-2b and ribavirin in combination during 24 weeks. Interferon alpha-2b was given subcutaneously, at a dose of

How to avoid discontinuation of ribaviri

How to avoid discontinuation of ribavirin in combination with interferon to maintain efficacy of treatment for chronic hepatitis C patients

✍ Akinori Kasahara 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 106 KB